Fujifilm Kyowa Kirin Biologics Company Ltd v Abbvie Biotechnology Ltd & Anor [2016] EWHC 2204 (Pat) (08 September 2016)
FKB has a real prospect of success in its claims for an Arrow declaration and an injunction against both AbbVie Bermuda and AbbVie UK. The court has jurisdiction to hear the claim against AbbVie Bermuda under Article 24(4) of the Recast Brussels I Regulation, as the claim is concerned with the validity of prospective European Patents (UK). The application for summary judgment or strike out by AbbVie is dismissed.
- Citation
- [2016] EWHC 2204 (Pat)
- Parties
- Claimant: Fujifilm Kyowa Kirin Biologics Company Limited; First Defendant: AbbVie Biotechnology Limited; Second Defendant: AbbVie Limited
- Jurisdiction
- England and Wales
- Judgment Date
- 08 September 2016
- Procedural Posture
- Patent Litigation / Interlocutory Application for Summary Judgment and Jurisdictional Challenge
- Outcome
- Application for summary judgment or strike out dismissed; permission to serve out granted; claim to proceed to trial.
- Legal Topics
- Patents, Declaratory Relief, Injunctions, Jurisdiction, Summary Judgment, Anti Suit Injunctions
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Fujifilm Kyowa Kirin Biologics Company Limited
Claimant
AbbVie Biotechnology Limited
First Defendant
AbbVie Limited
Second Defendant
Procedural Posture
Patent Litigation / Interlocutory Application for Summary Judgment and Jurisdictional Challenge
Legal Issues
- 1 Whether the claimant has a real prospect of success in obtaining an Arrow declaration against the defendants
- 2 Whether the claimant has a real prospect of success in obtaining an injunction against the defendants
- 3 Whether the English court has jurisdiction to hear the claim against the foreign defendant under the Recast Brussels I Regulation
Ratio Decidendi
FKB has a real prospect of success in its claims for an Arrow declaration and an injunction against both AbbVie Bermuda and AbbVie UK. The court has jurisdiction to hear the claim against AbbVie Bermuda under Article 24(4) of the Recast Brussels I Regulation, as the claim is concerned with the validity of prospective European Patents (UK). The application for summary judgment or strike out by AbbVie is dismissed.
Court Disposition
Application for summary judgment or strike out dismissed; permission to serve out granted; claim to proceed to trial.
Orders
- FKB's claims for an Arrow declaration and injunction to proceed to trial.
- Permission to serve the claim on AbbVie Bermuda outside the jurisdiction is upheld.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment